CAS 117414-74-1 appears in our catalog under these names: D-CPP-ene, D–CPP–ene, Midafotel, 99.00%. Offered by: TRC, GLPBio, MedChemExpress. Available pack sizes: 250mg, 10mg, 5 mg, 1 mg.
Midafotel is a member of the class of piperazines that is piperazine substituted by a carboxy group at position 2R and a (1E)-1-phosphonoprop-1-en-3-yl group at position 4. It is an antagonist of N-methyl-D-aspartate receptors (NMDARs) and was in clinical development by Novartis for the treatment of cognition disorders and brain injuries (now discontinued). It has a role as an anticonvulsant, a NMDA receptor antagonist and a neuroprotective agent. It is a monocarboxylic acid, a member of phosphonic acids, a piperazinecarboxylic acid, a tertiary amino compound and an olefinic compound.
Source: ChEBI
| Molecular formula | C8H15N2O5P |
|---|---|
| Molecular weight | 250.19 g/mol |
| IUPAC name | (2R)-4-[(E)-3-phosphonoprop-2-enyl]piperazine-2-carboxylic acid |
| InChIKey | VZXMZMJSGLFKQI-ABVWVHJUSA-N |
| SMILES | C1CN(C[C@@H](N1)C(=O)O)C/C=C/P(=O)(O)O |
Computed by PubChem (NCBI)